Aurobindo Pharma Ltd - Company Profile
Powered by 
All the sales intelligence you need on Aurobindo Pharma Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Aurobindo Pharma Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Aurobindo Pharma Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Aurobindo Pharma Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 29 Sep 2023 | Aurovitas Pharma (Taizhou) Co Ltd Enters Phase I Clinical Trial Agreement with AXIS Clinicals Ltd for doxazosin mesylate (GDCT0499429) | Contract Service Agreement |
Aurovitas Pharma (Taizhou) Co Ltd
|
AXIS Clinicals Ltd
|
| 01 Aug 2023 | CASI Pharma Enters into Licensing Agreement with Mundipharma International, Mundipharma Medical and Acrotech Biopharma | Licensing Agreement |
CASI Pharmaceuticals Inc
|
Acrotech Biopharma LLC
Mundipharma Medical Co
Mundipharma International Ltd
|
| 01 Aug 2023 | Aurovitas Pharma (Taizhou) Co Ltd Enters Phase I Clinical Trial Agreement with AXIS Clinicals Ltd for ezetimibe (GDCT0493944) | Contract Service Agreement |
Aurovitas Pharma (Taizhou) Co Ltd
|
AXIS Clinicals Ltd
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer